TELA Bio secures lender consent to waive minimum revenue covenant tests for Q3, Q4 2026

TELA•2026-09-29

TELA Bio received lender consent to suspend minimum revenue covenant testing for the quarters ending around September 30 and December 31, 2026.

1. Covenant waiver

TELA Bio entered a limited consent with Perceptive Credit Holdings V, as agent, and the required lenders under its November 2025 credit agreement. The consent suspends minimum revenue covenant testing for the quarters ending around September 30 and December 31, 2026.

Sources

TELA Bio secures lender consent to waive minimum revenue covenant tests for Q3, Q4 2026

Sec

TELA Bio secures lender consent to waive minimum revenue covenant tests for Q3, Q4 2026

1. Covenant waiver

Related News

PetMed Express names Jeffrey Allen Willard CEO and president, adds him to board

Hormel Foods promotes Aaron Asmus to VP of R&D

Baiya six-month net loss narrows on lower expenses, higher gross profit

Sources

TELA Bio secures lender consent to waive minimum revenue covenant tests for Q3, Q4 2026

Equities end slightly lower as bond yields hold near multi-decade highs

Leatt schedules annual shareholder meeting